2026 NPPES data Colon & Rectal Surgery Physician NPI 1376836452 MD
Verify on CMS →

TAFADZWA MAKARAWO, MD

Colon & Rectal Surgery Physician in GLENDALE, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
385
Medicare Part D claims · 220 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.8K
17 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TAFADZWA MAKARAWO, MD is a Colon & Rectal Surgery Physician ([object Object]) practicing in GLENDALE, Arizona with a Medicare Part D prescribing footprint of 385 claims across 220 beneficiaries — 17% brand-name prescribing . Industry payments of $1.8K across 17 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TAFADZWA MAKARAWO, MD filed 385 Medicare Part D claims in 2023 across GLENDALE, Arizona. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

TAFADZWA MAKARAWO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TAFADZWA MAKARAWO, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/23/2011

NPI 1376836452

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,608 US NPIs in this specialty

Medicare Part D claims

385 96% vs specialty avg

2023 prescription claims

Specialty avg: 196

Specialty distribution in Arizona

How Colon & Rectal Surgery Physician compares to other specialties among Arizona providers

Arizona providers

Colon & Rectal Surgery Physician share within Arizona

1. Colon & Rectal Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Colon & Rectal Surgery Physician share within Arizona

Specialty board-certification context

Estimated specialty board-certified rate — Colon & Rectal Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Colon & Rectal Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TAFADZWA MAKARAWO, MD is a Colon & Rectal Surgery Physician provider practicing in GLENDALE, Arizona, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1376836452. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TAFADZWA MAKARAWO, MD appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding MD credentials at 18275 N 59TH AVE STE M-176, GLENDALE, AZ, 85308, with a listed phone of (602) 993-2622. NPI 1376836452 was issued on 05/23/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAKARAWO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 385 prescription claims written by this provider, covering 220 Medicare beneficiaries and totaling roughly $18K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 13.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

18275 N 59TH AVE STE M-176
GLENDALE, AZ 85308

Provider Details

NPI 1376836452
Specialty Colon & Rectal Surgery Physician
Credentials MD
Gender Male
NPI Issued 05/23/2011

Hospital and facility affiliations

Facilities where TAFADZWA MAKARAWO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ARIZONA ADVANCED SURGERY LLC
GLENDALE, AZ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TAFADZWA MAKARAWO, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.8K

Largest payer

INTUITIVE SURGICAL, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

TAFADZWA MAKARAWO, MD — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 385 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

385
Total Claims
$18K
Total Drug Cost
220
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
391
Total Day Supply
3,569
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$11K
Generic Drug Cost
$7K
Opioid Claims
51 (13.2% rate)
Antibiotic Claims
66

Patient Demographics

Average Patient Age
69.5 years
Avg HCC Risk Score
1.67
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
36
Hydrocortisone
31
Metronidazole
27
Neomycin Sulfate
24
Cyclobenzaprine Hcl
14
Linzess
Linaclotide
12
Pantoprazole Sodium
11
Procto-Med Hc
Hydrocortisone
11
Gavilyte-G
"Peg3350/Sod Sulf
N/A
Peg-3350 And Electrolytes
"Peg3350/Sod Sulf
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How TAFADZWA MAKARAWO, MD fits within the Colon & Rectal Surgery Physician landscape nationally.

1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider

TAFADZWA MAKARAWO, MD's 385 claims are above the specialty average of 196.

Nearby Colon & Rectal Surgery Physician Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as MAKARAWO.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TAFADZWA MAKARAWO, MD's specialty?
TAFADZWA MAKARAWO, MD specializes in Colon & Rectal Surgery Physician and practices in GLENDALE, Arizona. Credentials: MD.
How much does TAFADZWA MAKARAWO, MD prescribe under Medicare Part D?
In 2023, TAFADZWA MAKARAWO, MD wrote 385 Medicare Part D claims totaling $18K in drug costs for 220 beneficiaries.
Where is TAFADZWA MAKARAWO, MD located?
TAFADZWA MAKARAWO, MD is located at 18275 N 59TH AVE STE M-176, GLENDALE, AZ, 85308. Phone: (602) 993-2622.
What is TAFADZWA MAKARAWO, MD's NPI number?
TAFADZWA MAKARAWO, MD's National Provider Identifier (NPI) is 1376836452, issued on 05/23/2011.
Does TAFADZWA MAKARAWO, MD prescribe more brand-name or generic drugs?
TAFADZWA MAKARAWO, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $11K in brand drug costs.
Does TAFADZWA MAKARAWO, MD prescribe opioids?
Yes, TAFADZWA MAKARAWO, MD had 51 opioid claims in 2023 with an opioid prescribing rate of 13.2%.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does TAFADZWA MAKARAWO, MD prescribe most often?
Based on 2023 Medicare Part D data, TAFADZWA MAKARAWO, MD's most frequently prescribed drugs include Oxycodone-Acetaminophen, Hydrocortisone, Metronidazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TAFADZWA MAKARAWO, MD accept Medicare?
TAFADZWA MAKARAWO, MD appears in CMS Medicare data with 385 Part D claims and 220 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TAFADZWA MAKARAWO, MD's credentials?
TAFADZWA MAKARAWO, MD's NPI is 1376836452 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology